http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107801711-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0221 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107801711-B |
| titleOfInvention | A kind of CIK cell frozen stock solution |
| abstract | The invention discloses a kind of using atractylenolide as the CIK cell frozen stock solution of protective ingredient; including serum free medium, serum and dimethyl sulfoxide; also contain atractylenolide; serum free medium is RPMI 1640; serum is the autoserum of fetal calf serum or the CIK cell donor; it is preferred that the autoserum of CIK cell donor, serum free medium, serum and dimethyl sulfoxide are mixed according to volume ratio 5:4:1.Present invention discover that the cryopreservation resuscitation rate of CIK cell can be improved in atractylenolide, and CIK cell is not influenced to the killing activity of tumour cell, it can be prepared into CIK cell frozen stock solution freezing for CIK cell, to guarantee that patient can feed back enough CIK cells after radiotherapy and chemotherapy. |
| priorityDate | 2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.